CD19+ B cell numbers predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis
View ORCID ProfileI. Schiavetti, L. Barcellini, View ORCID ProfileC. Lapucci, View ORCID ProfileF. Tazza, View ORCID ProfileM. Cellerino, View ORCID ProfileE. Capello, D. Franciotta, View ORCID ProfileM. Inglese, View ORCID ProfileM. P. Sormani, View ORCID ProfileA. Uccelli, View ORCID ProfileA. Laroni
doi: https://doi.org/10.1101/2022.07.02.22277178
I. Schiavetti
1Department of Health Sciences, Section of Biostatistics, University of Genova, Genova, Italy
L. Barcellini
2Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child University of Genova, Genova, Italy
C. Lapucci
3IRCCS Ospedale Policlinico San Martino, Genova, Italy
F. Tazza
2Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child University of Genova, Genova, Italy
M. Cellerino
2Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child University of Genova, Genova, Italy
E. Capello
3IRCCS Ospedale Policlinico San Martino, Genova, Italy
D. Franciotta
3IRCCS Ospedale Policlinico San Martino, Genova, Italy
M. Inglese
2Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child University of Genova, Genova, Italy
3IRCCS Ospedale Policlinico San Martino, Genova, Italy
M. P. Sormani
1Department of Health Sciences, Section of Biostatistics, University of Genova, Genova, Italy
3IRCCS Ospedale Policlinico San Martino, Genova, Italy
A. Uccelli
2Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child University of Genova, Genova, Italy
3IRCCS Ospedale Policlinico San Martino, Genova, Italy
A. Laroni
2Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child University of Genova, Genova, Italy
3IRCCS Ospedale Policlinico San Martino, Genova, Italy
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted July 05, 2022.
CD19+ B cell numbers predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis
I. Schiavetti, L. Barcellini, C. Lapucci, F. Tazza, M. Cellerino, E. Capello, D. Franciotta, M. Inglese, M. P. Sormani, A. Uccelli, A. Laroni
medRxiv 2022.07.02.22277178; doi: https://doi.org/10.1101/2022.07.02.22277178
CD19+ B cell numbers predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis
I. Schiavetti, L. Barcellini, C. Lapucci, F. Tazza, M. Cellerino, E. Capello, D. Franciotta, M. Inglese, M. P. Sormani, A. Uccelli, A. Laroni
medRxiv 2022.07.02.22277178; doi: https://doi.org/10.1101/2022.07.02.22277178
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (626)
- Anesthesia (162)
- Cardiovascular Medicine (2352)
- Dermatology (206)
- Emergency Medicine (377)
- Epidemiology (11739)
- Forensic Medicine (10)
- Gastroenterology (698)
- Genetic and Genomic Medicine (3712)
- Geriatric Medicine (347)
- Health Economics (632)
- Health Informatics (2383)
- Health Policy (928)
- Hematology (340)
- HIV/AIDS (775)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (397)
- Neurology (3468)
- Nursing (197)
- Nutrition (521)
- Oncology (1809)
- Ophthalmology (534)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (232)
- Palliative Medicine (66)
- Pathology (445)
- Pediatrics (1026)
- Primary Care Research (417)
- Public and Global Health (6115)
- Radiology and Imaging (1268)
- Respiratory Medicine (823)
- Rheumatology (379)
- Sports Medicine (320)
- Surgery (398)
- Toxicology (50)
- Transplantation (171)
- Urology (145)